Subjects at greater risk of HHF aftertaking sitagliptin were those without severe hypoglycemia, without ACE inhibitorstreatment, with history of heart failure or receiving hemodialysis rather thanperitoneal dialysis. This evidence concerns the gene ACE and heart failure.